https://www.selleckchem.com/pr....oducts/lonafarnib-sc
The fully adjusted OR of depressive symptoms was 1.637 (1.087-2.467) in quartile 4 (the highest) versus quartile 1 (the lowest) of the trans fatty acid intake. Sensitivity analyses performed in women with baseline CES-D score less then 16 showed that this association remained statistically significant. LIMITATIONS Assessment of depression and trans fatty acid intake was based on a self-report scale. CONCLUSIONS Trans fatty acid intake is a predictor for depressive symptoms 5 years later in midlife women independent health an